Lars Kattner

836 total citations · 1 hit paper
21 papers, 623 citations indexed

About

Lars Kattner is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lars Kattner has authored 21 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 5 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Lars Kattner's work include Vitamin D Research Studies (4 papers), Synthetic Organic Chemistry Methods (3 papers) and Chemical Reactions and Isotopes (3 papers). Lars Kattner is often cited by papers focused on Vitamin D Research Studies (4 papers), Synthetic Organic Chemistry Methods (3 papers) and Chemical Reactions and Isotopes (3 papers). Lars Kattner collaborates with scholars based in Germany, Austria and Egypt. Lars Kattner's co-authors include Patrick Mäder, Johann Mulzer, Christian D. Klein, Christian Steuer, Peter Luger, Christian Schroeder, C.W. Lehmann, Erik Rauch, Rolf W. Hartmann and Stefan Zimmermann and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Lars Kattner

20 papers receiving 614 citations

Hit Papers

Sulfoximines as Rising Stars in Modern Drug Discovery? Cu... 2020 2026 2022 2024 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Kattner Germany 12 378 181 64 46 40 21 623
Mark W. Ledeboer United States 12 253 0.7× 247 1.4× 31 0.5× 16 0.3× 11 0.3× 18 607
Olivier Corminboeuf Switzerland 16 349 0.9× 231 1.3× 52 0.8× 21 0.5× 23 0.6× 24 666
John P. Caldwell United States 13 173 0.5× 186 1.0× 13 0.2× 47 1.0× 46 1.1× 22 392
Peter G. Nell Germany 11 287 0.8× 213 1.2× 36 0.6× 21 0.5× 7 0.2× 14 544
I Galatulas Italy 15 357 0.9× 136 0.8× 24 0.4× 36 0.8× 9 0.2× 78 575
Douglas C. Beshore United States 16 451 1.2× 391 2.2× 56 0.9× 90 2.0× 16 0.4× 29 750
Joseph A. Finkelstein United States 11 337 0.9× 303 1.7× 70 1.1× 30 0.7× 13 0.3× 17 575
Kelvin Cooper United States 15 449 1.2× 331 1.8× 18 0.3× 21 0.5× 12 0.3× 30 714
G.F. Ruda United Kingdom 15 131 0.3× 513 2.8× 55 0.9× 113 2.5× 5 0.1× 20 719
Rita L. Civiello United States 12 222 0.6× 150 0.8× 8 0.1× 23 0.5× 16 0.4× 20 425

Countries citing papers authored by Lars Kattner

Since Specialization
Citations

This map shows the geographic impact of Lars Kattner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Kattner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Kattner more than expected).

Fields of papers citing papers by Lars Kattner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Kattner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Kattner. The network helps show where Lars Kattner may publish in the future.

Co-authorship network of co-authors of Lars Kattner

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Kattner. A scholar is included among the top collaborators of Lars Kattner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Kattner. Lars Kattner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kattner, Lars, et al.. (2022). Efficient Asymmetric Synthesis of an A‐Ring Synthon for Pd‐Catalyzed Preparation of 1α‐Hydroxyvitamin D Metabolites and Analogs. European Journal of Organic Chemistry. 2022(33). 1 indexed citations
2.
Kattner, Lars, et al.. (2020). Highly regio- and stereoselective hydroxylation of vitamin D2 by CYP109E1. Biochemical and Biophysical Research Communications. 524(2). 295–300. 11 indexed citations
3.
Mäder, Patrick & Lars Kattner. (2020). Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry. Journal of Medicinal Chemistry. 63(23). 14243–14275. 295 indexed citations breakdown →
4.
Kattner, Lars & Erik Rauch. (2020). Efficient synthesis of 3-TBDMS-11α,25-dihydroxyvitamin D3 and D2 ethers. The Journal of Steroid Biochemistry and Molecular Biology. 200. 105638–105638. 1 indexed citations
5.
Kattner, Lars. (2019). Recent Developments Towards the Synthesis of Vitamin D Metabolites. Anticancer Research. 40(1). 519–525. 1 indexed citations
6.
Mohamed, Belal A., Nico Hartmann, Petros Tirilomis, et al.. (2018). Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression. Science Translational Medicine. 10(458). 27 indexed citations
7.
Kattner, Lars, et al.. (2017). An efficient synthesis of 1α,25-dihydroxyvitamin D3 LC-biotin. The Journal of Steroid Biochemistry and Molecular Biology. 173. 89–92. 4 indexed citations
8.
Kattner, Lars & Erik Rauch. (2016). Optimization of Chemical Syntheses of Vitamin D C3-Epimers.. PubMed. 36(3). 1417–21. 2 indexed citations
9.
Erbguth, Karen, Arend Vogt, Thomas Riemensperger, et al.. (2014). Synthetic retinal analogues modify the spectral and kinetic characteristics of microbial rhodopsin optogenetic tools. Nature Communications. 5(1). 5810–5810. 36 indexed citations
10.
Kattner, Lars. (2014). Development of efficient chemical syntheses of Vitamin D degradation products. PubMed. 35(2). 1205–10. 2 indexed citations
11.
Gribbon, Philip, Bernhard Ellinger, Jeanette Reinshagen, et al.. (2013). Development of a Colorimetric and a Fluorescence Phosphatase-Inhibitor Assay Suitable for Drug Discovery Approaches. SLAS DISCOVERY. 18(8). 899–909. 18 indexed citations
12.
Zimmermann, Stefan, et al.. (2012). Chemical, biochemical and microbiological properties of a brominated nitrovinylfuran with broad-spectrum antibacterial activity. Bioorganic & Medicinal Chemistry. 21(3). 795–804. 25 indexed citations
13.
Steuer, Christian, et al.. (2009). Optimization of Assay Conditions for Dengue Virus Protease: Effect of Various Polyols and Nonionic Detergents. SLAS DISCOVERY. 14(9). 1102–1108. 46 indexed citations
14.
Kronenberger, Bernd, Artur Kaul, Ralf Bartenschlager, et al.. (2008). Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization. Molecules. 13(5). 1081–1110. 16 indexed citations
15.
Mulzer, Johann, et al.. (2004). A mechanistic study of the Hiyama–Nozaki allylation: evidence for radical intermediates. Tetrahedron Letters. 45(48). 8867–8870. 12 indexed citations
16.
Kattner, Lars, et al.. (1995). Synthesis and Biochemical Evaluation of (Carbamoylalkenyl)phenyloxy Carboxylic Acid Derivatives as Non‐steroidal 5α‐Reductase Inhibitors. Archiv der Pharmazie. 328(3). 239–245. 10 indexed citations
18.
Mulzer, Johann, et al.. (1991). Highly Felkin-Anh selective Hiyama additions of chiral allylic bromides to aldehydes. Application to the first synthesis of nephromopsinic acid and its enantiomer. Journal of the American Chemical Society. 113(11). 4218–4229. 53 indexed citations
19.
Mulzer, Johann & Lars Kattner. (1990). Doubly Stereodifferentiating Hiyama Addition with Mismatched Reactants; Enantio‐ and Diastereo‐controlled Synthesis of Dihydrocanadensolide. Angewandte Chemie International Edition in English. 29(6). 679–680. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026